期刊
IMMUNOTHERAPY
卷 8, 期 2, 页码 211-221出版社
FUTURE MEDICINE LTD
DOI: 10.2217/imt.15.110
关键词
adoptive immunotherapy; cytomegalovirus; immunotherapy; memory T cells; vaccination
类别
资金
- NIAID NIH HHS [R01 AI106810] Funding Source: Medline
Cytomegalovirus (CMV) is a beta-herpesvirus that infects most people in the world and is almost always asymptomatic in the healthy host. However, CMV persists for life, requiring continuous immune surveillance to prevent disease and thus, CMV is a frequent complication in immune compromised patients. Many groups have been exploring the potential for adoptive T-cell therapies to control CMV reactivation as well as the progression of solid tumors harboring CMV. In addition, CMV itself is being explored as a vaccine vector for eliciting potent T-cell responses. This review will discuss key features of the basic biology of CMV-specific T cells as well as highlighting unanswered questions and ongoing work in the development of T-cell-based immunotherapies to target CMV.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据